LRRK2 and Parkinson disease: Subsequently, we selected the protocol using the TGFb3 molecule for further differentiations and studied the disparities between hiPSC-derived pericyte-like cells that were differentiated from healthy lines and PD lines with the LRRK2 G2019S mutation.